SL
Sean Laaman Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
4.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
75%
Neutral
20.8%
Negative
4.2%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $32 |
111%
upside
| 1 | +10% |
0
%
| 2 Mar ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $98 |
47%
upside
| 2 | -4.8% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Equal-Weight
Maintained
| $49 |
18%
upside
| 6 | +2% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $204 |
24%
upside
| 4 | +18% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $12 |
63%
upside
| 2 | – |
–
| 18 Dec ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $20 |
97%
upside
| 1 | -12% |
0
%
| 5 Dec ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $34 |
89%
upside
| 1 | +36% |
0
%
| 21 Nov ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $115 |
88%
upside
| 3 | +8.8% |
0
%
| 30 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $304 |
17%
upside
| 1 | -4.6% |
0
%
| 21 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $383 |
28%
upside
| 2 | +9.4% |
0
%
| 20 Oct ‘25 4 months ago |
|
|
|
Underweight
Assumed
| $1.50 |
30%
downside
| 1 | -36% |
0
%
| 7 Mar ‘25 1 year ago |
|